Dr. Jodi Gilman, Identification of THC Impairment Using Functional Brain Imaging

July 2023

Dr. Jodi Gilman is an Associate Professor in Psychiatry at Harvard Medical School and the Director of Neuroscience at the Massachusetts General Hospital Center for Addiction Medicine. She received her PhD in Neuroscience from Brown University. Dr. Gilman’s research uses multi-modal imaging, behavioral and cognitive testing to understand the biological, psychological, and clinical aspects of addiction. Specifically, she studies the effects of cannabis use on addiction and other health outcomes. Her goal is to conduct research that can inform decision-making among the public, patients, and clinicians regarding evidence-based decisions to use or not use cannabis for recreational or medical purposes. Her work has been featured in media outlets throughout the world, including Reuters, NPR’s Science Friday, and the BBC.

Dr. Gilman has received numerous awards, including the Fellows Award for Research Excellence from the National Institutes of Health.

Previous Webinars

Devan Kansagara, MD., MCR.

June 12th 1:00 PM MST

Systematically Testing the Evidence on Marijuana (STEM): Bridging the Science of Cannabis Health Effects and Clinical Practice

Devan Kansagara MD, MCR is a Professor of Medicine at Oregon Health and Science University. He practices and teaches primary care and hospital-based internal medicine in the VA Portland Health Care System. His work in […]

Read More »

Nolan Kane, PhD.

May 21, 2025 11:00 AM Mountain Time

Genetics, chemistry and the evolution of sex chromosomes in Cannabis

Dr. Nolan Kane is an associate professor in the ebio department at the university of Colorado, boulder. he uses genomic approaches to study adaptation to new environments, domestication of wild plants into valuable crops, and the formation of new species. his […]

Read More »

Dan Covey, PhD.

May 8, 2025, 1:00 PM

Effects of isolated cannabinoids and endocannabinoids on emotional behavior in rodents

Dr. Covey is currently an Assistant Professor at Lovelace Biomedical Research Institute (LBRI) in Albuquerque, New Mexico. He started this position in June 2020 after completing his PhD at Illinois State University and a postdoctoral fellowship at the University of Maryland […]

Read More »

Andrew Kesner, PhD

Preclinical modeling of spontaneous Δ-9-THC withdrawal symptoms in mice: sleep, dopamine, and behavioral maladaptations

April 10th, 1:00PM MST

Dr. Kesner is the Chief of the Unit on Motivation and Arousal at National Institute on Alcohol Abuse and Alcoholism (NIAAA). The mission of his lab is to use systems neuroscience approaches to understand how brain systems controlling motivated […]

Read More »

Roberta Paris, PhD.

Genetic, molecular and biochemical studies on the accumulation of bioactive compounds in Cannabis sativa L.

19 March, 2025, 11:00 AM  

Dr. Roberta Paris studied at the Alma Mater Studiorum, University of Bologna, where she obtained the PhD in Cellular and Molecular Biology in 2006. She is a permanent researcher at Council for Agricultural Research and Economic, Research […]

Read More »

Sarah D. Lichenstein, PhD.

Neural mechanisms of risk for problem-level cannabis use among emerging adults

Dr. Lichenstein is a licensed clinical psychologist, an Assistant Professor of Psychiatry, and Assistant Director of the Yale Imaging and Psychopharmacology Lab at Yale School of Medicine. She received her BA in Psychology from Bard College (2008), and her PhD in Clinical Psychology from the […]

Read More »